U.S. Alpha-1 Antitrypsin Deficiency (AATD) Augmentation Market is...

adicionou um novo artigo SEO/ SMM /SEM

2023-01-31 06:10:36 - Traduzir

U.S. Alpha-1 Antitrypsin Deficiency (AATD) Augmentation Market is Surge to Witness Huge Demand at a CAGR of 9.0% during the forecast period 2029

U.S. alpha-1 antitrypsin deficiency (AATD) augmentation therapy market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is expected to reach USD 1,052.03 million by 2029 from USD 563.24 million in 2021, growing with a CAGR of 9.0% in the forecast period of 2022 to 2029. Insights covered in the wide ranging U.S....

0 Comentários 0 Compartilhamentos 947 Visualizações 0 Anterior